OAM
STML

Oxford Asset Management’s Stemline Therapeutics, Inc. STML Stock Holding History

Oxford Asset Management’s Portfolio STML Stock Details STML Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
2019
Q3 		$597K Buy
2017
Q1 		– Sell
2016
Q4 		$431K Buy
2016
Q3 		– Sell
2016
Q2 		$616K Sell
2016
Q1 		$579K Sell
2015
Q4 		$1.13M Buy